Franklin Street Advisors’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-3,142
| Closed | -$41K | – | 160 |
|
|
2019
Q4 | $41K | Buy |
3,142
+2,000
| +175% | +$26.1K | ﹤0.01% | 152 |
|
|
2019
Q3 | $12K | Hold |
1,142
| – | – | ﹤0.01% | 157 |
|
|
2019
Q2 | $19K | Hold |
1,142
| – | – | ﹤0.01% | 159 |
|
|
2019
Q1 | $38K | Sell |
1,142
-4,000
| -78% | -$133K | 0.01% | 156 |
|
|
2018
Q4 | $150K | Buy |
5,142
+130
| +3% | +$3.79K | 0.02% | 138 |
|
|
2018
Q3 | $309K | Sell |
5,012
-43
| -0.9% | -$2.65K | 0.04% | 127 |
|
|
2018
Q2 | $373K | Buy |
5,055
+86
| +2% | +$6.35K | 0.05% | 117 |
|
|
2018
Q1 | $326K | Buy |
4,969
+140
| +3% | +$9.19K | 0.05% | 126 |
|
|
2017
Q4 | $406K | Buy |
4,829
+3,600
| +293% | +$303K | 0.06% | 115 |
|
|
2017
Q3 | $142K | Buy |
+1,229
| New | +$142K | 0.02% | 150 |
|
|
2017
Q2 | – | Sell |
-2,559
| Closed | -$316K | – | 163 |
|
|
2017
Q1 | $316K | Buy |
+2,559
| New | +$316K | 0.06% | 131 |
|